Clinical Trial Update: Nab-Paclitaxel as Salvage Treatment in Locally Advanced or Metastatic Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nab-paclitaxel as salvage therapy in locally advanced or metastatic gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Hellenic Oncology Research Group | Conditions: Stomach and Gastro-Esophageal Junction (GEJ) Cancer | Phase 2 | Status: COMPLETED